CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $84.63 billion. The enterprise value is $152.46 billion.
| Market Cap | 84.63B |
| Enterprise Value | 152.46B |
Important Dates
The last earnings date was Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | Apr 22, 2025 |
Share Statistics
CVS Health has 1.27 billion shares outstanding. The number of shares has decreased by -1.77% in one year.
| Current Share Class | 1.27B |
| Shares Outstanding | 1.27B |
| Shares Change (YoY) | -1.77% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 84.59% |
| Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 15.96 and the forward PE ratio is 10.72. CVS Health's PEG ratio is 0.71.
| PE Ratio | 15.96 |
| Forward PE | 10.72 |
| PS Ratio | 0.22 |
| Forward PS | 0.21 |
| PB Ratio | 1.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.12 |
| P/OCF Ratio | 9.58 |
| PEG Ratio | 0.71 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.94, with an EV/FCF ratio of 25.66.
| EV / Earnings | 28.87 |
| EV / Sales | 0.40 |
| EV / EBITDA | 10.94 |
| EV / EBIT | 16.34 |
| EV / FCF | 25.66 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.05.
| Current Ratio | 0.82 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | 4.79 |
| Debt / FCF | 13.67 |
| Interest Coverage | 3.08 |
Financial Efficiency
Return on equity (ROE) is 6.93% and return on invested capital (ROIC) is 3.71%.
| Return on Equity (ROE) | 6.93% |
| Return on Assets (ROA) | 2.31% |
| Return on Invested Capital (ROIC) | 3.71% |
| Return on Capital Employed (ROCE) | 5.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.49 |
| Inventory Turnover | 19.31 |
Taxes
In the past 12 months, CVS Health has paid $1.94 billion in taxes.
| Income Tax | 1.94B |
| Effective Tax Rate | 27.01% |
Stock Price Statistics
The stock price has increased by +19.46% in the last 52 weeks. The beta is 0.60, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +19.46% |
| 50-Day Moving Average | 66.63 |
| 200-Day Moving Average | 59.20 |
| Relative Strength Index (RSI) | 50.84 |
| Average Volume (20 Days) | 11,137,743 |
Short Selling Information
The latest short interest is 18.65 million, so 1.47% of the outstanding shares have been sold short.
| Short Interest | 18.65M |
| Short Previous Month | 19.88M |
| Short % of Shares Out | 1.47% |
| Short % of Float | 1.48% |
| Short Ratio (days to cover) | 1.69 |
Income Statement
In the last 12 months, CVS Health had revenue of $376.74 billion and earned $5.28 billion in profits. Earnings per share was $4.19.
| Revenue | 376.74B |
| Gross Profit | 51.02B |
| Operating Income | 9.33B |
| Pretax Income | n/a |
| Net Income | 5.28B |
| EBITDA | 13.94B |
| EBIT | 9.33B |
| Earnings Per Share (EPS) | $4.19 |
Balance Sheet
The company has $12.65 billion in cash and $81.21 billion in debt, giving a net cash position of -$68.56 billion or -$54.20 per share.
| Cash & Cash Equivalents | 12.65B |
| Total Debt | 81.21B |
| Net Cash | -68.56B |
| Net Cash Per Share | -$54.20 |
| Equity (Book Value) | 77.11B |
| Book Value Per Share | 60.96 |
| Working Capital | -15.77B |
Cash Flow
In the last 12 months, operating cash flow was $8.76 billion and capital expenditures -$2.82 billion, giving a free cash flow of $5.94 billion.
| Operating Cash Flow | 8.76B |
| Capital Expenditures | -2.82B |
| Free Cash Flow | 5.94B |
| FCF Per Share | $4.70 |
Margins
Gross margin is 13.54%, with operating and profit margins of 2.48% and 1.40%.
| Gross Margin | 13.54% |
| Operating Margin | 2.48% |
| Pretax Margin | 1.91% |
| Profit Margin | 1.40% |
| EBITDA Margin | 3.70% |
| EBIT Margin | 2.48% |
| FCF Margin | 1.58% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.98%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.98% |
| Dividend Growth (YoY) | 4.72% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 63.47% |
| Buyback Yield | 1.77% |
| Shareholder Yield | 5.78% |
| Earnings Yield | 6.29% |
| FCF Yield | 7.08% |
Analyst Forecast
The average price target for CVS Health is $75.33, which is 12.60% higher than the current price. The consensus rating is "Buy".
| Price Target | $75.33 |
| Price Target Difference | 12.60% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 4.50% |
| EPS Growth Forecast (5Y) | 21.95% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.12 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 6 |